RPS in West Yorkshire

02/03/2020

RPS in West Yorkshire Symposium: Cross Sector Pharmacy Integration: Supporting the Path of Least Resistance. What Will You Change Today, to Make a Difference Tomorrow?
Free for RPS members, £20 for non-members. Sunday 15th March, 9:30am, Brighouse

Book here:
https://events.rpharms.com/website/1452/?utm_source=Royal%20Pharmaceutical%20Society&utm_medium=email&utm_campaign=11301497_West%20Yorkshire%20local%20event&dm_t=0,0,0,0,0

14/09/2019

Investigation around possible impurities in ranitidine medicines.

Drug regulators in the US and Europe find the probable carcinogen NDMA in heartburn medicines containing ranitidine, reminiscent of the 'sartan' contamination saga.

26/07/2019

RPS Annual Conference 2019: Medicines Safety
Sunday 17 November 2019
etc.venues 133 Houndsditch, Liverpool Street, London, EC3A 7BX

Free for RPS Members!
We're delighted to invite RPS Members to attend the RPS Annual Conference 2019 free-of-charge.
To secure your place though, we do require a £30 deposit.
Don't worry - this will be refunded to you automatically when we see you at the event!

https://events.rpharms.com/website/393/

This year’s exciting programme is focusing on medicines safety, one of the most challenging and dominant issues facing health care systems on a global scale. It’s a perfect fit with the RPS’ wider vision to be the world leader in the safe and effective use of medicines.

30/05/2019

16/10/2018

Every wonder where all those wonderful medical leeches come from?

They were once used to treat everything from headaches to strangulation, and leeches are still a vital part of surgery. But how are they farmed?

10/09/2018

Continuing the success of the first RPS Winter Summit, the RPS will be hosting the RPS Science & Research Summit.

Chaired by RPS Chief Scientist, Gino Martini, the speaker programme is comprised of experts and influencers who are pushing the boundaries of innovation in the pharmaceutical sciences, research and education across industry, academia and practice. It provides a forum for knowledge translation and an opportunity to develop new ideas and innovations.
https://www.rpharms.com/Portals/0/Groups/133/RPS Science and Research Stakeholder Advert - Final.pdf?ver=2018-09-10-133315-190

The RPS Winter Summit showcases the latest research, evidence and innovation across the pharmaceutical sciences and education

26/07/2018

Cannabis-based medicines get green light as UK eases rules.
To be re-classified as CD2 once a definition can be agreed
https://t.co/SJoJmZRh7E

Relaxation of laws means doctors will be able to give medicinal cannabis prescriptions

24/07/2018

Painkiller used for dementia 'could make symptoms worse' https://t.co/0sCiVpqJv5

Buprenorphine linked to an increase in side-effects including sedation and confusion, scientists find

19/07/2018

Routine treatment for cardiac arrest doubles risk of brain damage – study. Adrenaline may be good for starting the heart but bad for the brain https://t.co/6pCft8QRvG

Landmark trial likely to change the way cardiac arrest has been treated in the UK for more than half a century

19/07/2018

ASA ruling on Pharmacy2U advertising https://t.co/ghLma32CoR

AdviceOnline entries provide guidance on interpreting the UK Code of Non-broadcast Advertising and Direct & Promotional Marketing.

18/07/2018

Omega-3 no protection against heart attack or strokes, say scientists https://t.co/uUQO0wVXx2

Supplements do not offer cardiovascular benefits, researchers conclude from trials involving 112,000 people

17/07/2018

MHRA consultation on "Implementing ‘safety features’ under the Falsified Medicines Directive". Covers both the 2D barcode and anti-tamper features https://t.co/eZoAjEuWNK

This consultation invites views on the proposed steps we intend to take to make sure the UK meets its obligations to transpose the 'safety features' provisions of the Falsified Medicines Directive (FMD).

05/07/2018

Class 1 Medicines Recall - Valsartan by Actavis / Accord / Dexcel https://t.co/hqrGRv9VYC

Pharmacies in the UK are being advised to recall all batches of valsartan containing medicines made by Actavis Group PTC (now Accord) and Dexcel Pharma Ltd due to contamination.

14/05/2018

Digital informatics and early-career pharmacy professionals https://t.co/MVPVWkUjiJ
Survey open until 16-May

03/05/2018

Class 3 Medicines Recall for Latanoprost Timolol Eye drops.
FDC Pharma are recalling batch 087B087 due to an out of specification result for an unknown impurity during stability testing. (EL(18)A/08) https://t.co/VjOvgSAJx7

“Support Alert: Class 3 Medicines Recall: Latanoprost Timolol Eye drops https://t.co/CXCz205Qgo ”

03/05/2018

BBC News - Bath additives for child eczema ineffective, study finds https://t.co/dmBLwjfDov

Experts say the findings suggest the NHS could better spend the £23m each year it costs for the treatment.